UICC Opens the World Cancer Leaders’ Summit 2025

World Cancer Leaders UICC

“Delivering Innovation with Integrity” - ACT 4 Children Initiative at the 2025 WCLS

ACT 4 Children

Top Growing Medical Universities in USA and Canada: 2025 Edition by BIGR

USA and Canada

Pediatric Cardio-Oncology Consortium to Host Virtual Summit on December 4, 2025

Cardio-Oncology-Consortium

10 Oncology Experts Join OncoDaily Medical Journal’s Editorial Team

OncoDaily Medical Journal

2025 Selected Abstracts for the European Cancer Summit - European Cancer Organisation

European Cancer Organisation European Cancer Summit

FDA Approves Ziftomenib (Komzifti) for Relapsed or Refractory NPM1-Mutated Acute Myeloid Leukemia

ziftomenib

The World’s First Trial of a Vaccine to Prevent Lung Cancer - Cancer Research UK

Cancer Research UK

OncoCalendar

« All Events

  • This event has passed.

2025 FDA-AACR Workshop: Approach to Novel Oncology Endpoint Development

Sep 11 • 8:00 AM - 3:30 PM
2025 FDA-AACR Workshop

U.S. FDA Oncology Center of Excellence and the American Association for Cancer Research (AACR), will host a one-day hybrid workshop on September 11, 2025, at the Hilton Alexandria Old Town. 2025 FDA-AACR Workshop will address the challenges and opportunities in using novel clinical trial endpoints that can inform regulatory decisions, especially in early-stage and rare cancers where overall survival measurement may be impractical.

Key topics include past successes in endpoint development, evidence requirements to validate novel endpoints, balancing risks and benefits, and leveraging these endpoints within accelerated approval pathways. The workshop will feature case studies and discussions led by experts from regulatory agencies, academia, industry, and patient advocacy.

Details

Organizer

Venue